Temporal trends and autopsy findings of SUDEP based on medico-legal investigations in the United States.


Journal

Neurology
ISSN: 1526-632X
Titre abrégé: Neurology
Pays: United States
ID NLM: 0401060

Informations de publication

Date de publication:
18 08 2020
Historique:
received: 10 06 2019
accepted: 28 01 2020
pubmed: 9 7 2020
medline: 21 10 2020
entrez: 9 7 2020
Statut: ppublish

Résumé

To determine time trends and distinguishing autopsy findings of sudden unexpected death in epilepsy (SUDEP) in the United States. We identified decedents where epilepsy/seizure was listed as cause/contributor to death or comorbid condition on the death certificate among all decedents who underwent medico-legal investigation at 3 medical examiner (ME) offices across the country: New York City (2009-2016), San Diego County (2008-2016), and Maryland (2000-2016). After reviewing all available reports, deaths classified as definite/probable/near SUDEP or SUDEP plus were included for analysis. Mann-Kendall trend test was used to analyze temporal trends in SUDEP rate for 2009-2016. Definite SUDEPs were compared to sex- and age ±2 years-matched non-SUDEP deaths with a history of epilepsy regarding autopsy findings, circumstances, and comorbidities. A total of 1,086 SUDEP cases were identified. There was a decreasing trend in ME-investigated SUDEP incidence between 2009 and 2016 ( There was a decreasing monotonic trend in ME-investigated SUDEP incidence over 8 years, with a 28% reduction in incidence from 2009-2012 to 2013-2016. Unlike SIDS and sudden cardiac death, we found no correlation between SUDEP and the season of year or day of week. No autopsy findings distinguished SUDEP from non-SUDEP deaths.

Identifiants

pubmed: 32636323
pii: WNL.0000000000009996
doi: 10.1212/WNL.0000000000009996
pmc: PMC7605498
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e867-e877

Subventions

Organisme : NCATS NIH HHS
ID : UL1 TR001445
Pays : United States

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© 2020 American Academy of Neurology.

Références

N Engl J Med. 2010 Dec 23;363(26):2522-9
pubmed: 21175314
Heart Fail Clin. 2017 Oct;13(4):703-717
pubmed: 28865780
Epilepsia. 2014 Oct;55(10):1486-94
pubmed: 25323807
Epilepsy Res. 2006 Feb;68(2):137-43
pubmed: 16423504
Acta Paediatr. 1998 Oct;87(10):1033-8
pubmed: 9825968
Neurology. 2017 Jul 11;89(2):170-177
pubmed: 28592455
Epilepsia. 2018 Aug;59(8):e120-e124
pubmed: 29905938
Clin Neurol Neurosurg. 2017 Jul;158:82-89
pubmed: 28500925
JAMA Neurol. 2018 May 1;75(5):531-532
pubmed: 29710173
Int J Epidemiol. 2014 Dec;43(6):1969-85
pubmed: 25080530
Epilepsia. 2018 May;59(5):1074-1082
pubmed: 29663344
Epilepsy Behav. 2016 Feb;55:184-8
pubmed: 26627980
Neurology. 2018 Jul 10;91(2):e107-e111
pubmed: 29884734
Eur Heart J. 2000 Feb;21(4):315-20
pubmed: 10653679
Neurology. 2017 Aug 29;89(9):886-892
pubmed: 28768851
Epilepsia. 2018 Mar;59(3):562-572
pubmed: 29336017
Neurology. 2018 Jul 3;91(1):e55-e61
pubmed: 29858472
Epilepsia. 2012 Feb;53(2):227-33
pubmed: 22191982
Lancet Neurol. 2018 Nov;17(11):977-985
pubmed: 30219655
Neurology. 2017 Apr 25;88(17):1674-1680
pubmed: 28438841

Auteurs

Esma Cihan (E)

From the Department of Neurology (E.C., O.D., M.W.K., J.E.Y., D.F.), NYU School of Medicine; Department of Epidemiology (D.C.H.), Columbia University Medical Center, New York, NY; San Diego County Medical Examiner's Office (M.B.), CA; Maryland Office of the Chief Medical Examiner (L.L., D.R.F.), Baltimore; New York City Office of Chief Medical Examiner (J.K.G.), New York; and Division of Neurology, Department of Paediatrics (A.E.K., E.J.D.), the Hospital for Sick Children, Toronto, Canada.

Orrin Devinsky (O)

From the Department of Neurology (E.C., O.D., M.W.K., J.E.Y., D.F.), NYU School of Medicine; Department of Epidemiology (D.C.H.), Columbia University Medical Center, New York, NY; San Diego County Medical Examiner's Office (M.B.), CA; Maryland Office of the Chief Medical Examiner (L.L., D.R.F.), Baltimore; New York City Office of Chief Medical Examiner (J.K.G.), New York; and Division of Neurology, Department of Paediatrics (A.E.K., E.J.D.), the Hospital for Sick Children, Toronto, Canada.

Dale C Hesdorffer (DC)

From the Department of Neurology (E.C., O.D., M.W.K., J.E.Y., D.F.), NYU School of Medicine; Department of Epidemiology (D.C.H.), Columbia University Medical Center, New York, NY; San Diego County Medical Examiner's Office (M.B.), CA; Maryland Office of the Chief Medical Examiner (L.L., D.R.F.), Baltimore; New York City Office of Chief Medical Examiner (J.K.G.), New York; and Division of Neurology, Department of Paediatrics (A.E.K., E.J.D.), the Hospital for Sick Children, Toronto, Canada.

Michael Brandsoy (M)

From the Department of Neurology (E.C., O.D., M.W.K., J.E.Y., D.F.), NYU School of Medicine; Department of Epidemiology (D.C.H.), Columbia University Medical Center, New York, NY; San Diego County Medical Examiner's Office (M.B.), CA; Maryland Office of the Chief Medical Examiner (L.L., D.R.F.), Baltimore; New York City Office of Chief Medical Examiner (J.K.G.), New York; and Division of Neurology, Department of Paediatrics (A.E.K., E.J.D.), the Hospital for Sick Children, Toronto, Canada.

Ling Li (L)

From the Department of Neurology (E.C., O.D., M.W.K., J.E.Y., D.F.), NYU School of Medicine; Department of Epidemiology (D.C.H.), Columbia University Medical Center, New York, NY; San Diego County Medical Examiner's Office (M.B.), CA; Maryland Office of the Chief Medical Examiner (L.L., D.R.F.), Baltimore; New York City Office of Chief Medical Examiner (J.K.G.), New York; and Division of Neurology, Department of Paediatrics (A.E.K., E.J.D.), the Hospital for Sick Children, Toronto, Canada.

David R Fowler (DR)

From the Department of Neurology (E.C., O.D., M.W.K., J.E.Y., D.F.), NYU School of Medicine; Department of Epidemiology (D.C.H.), Columbia University Medical Center, New York, NY; San Diego County Medical Examiner's Office (M.B.), CA; Maryland Office of the Chief Medical Examiner (L.L., D.R.F.), Baltimore; New York City Office of Chief Medical Examiner (J.K.G.), New York; and Division of Neurology, Department of Paediatrics (A.E.K., E.J.D.), the Hospital for Sick Children, Toronto, Canada.

Jason K Graham (JK)

From the Department of Neurology (E.C., O.D., M.W.K., J.E.Y., D.F.), NYU School of Medicine; Department of Epidemiology (D.C.H.), Columbia University Medical Center, New York, NY; San Diego County Medical Examiner's Office (M.B.), CA; Maryland Office of the Chief Medical Examiner (L.L., D.R.F.), Baltimore; New York City Office of Chief Medical Examiner (J.K.G.), New York; and Division of Neurology, Department of Paediatrics (A.E.K., E.J.D.), the Hospital for Sick Children, Toronto, Canada.

Michael W Karlovich (MW)

From the Department of Neurology (E.C., O.D., M.W.K., J.E.Y., D.F.), NYU School of Medicine; Department of Epidemiology (D.C.H.), Columbia University Medical Center, New York, NY; San Diego County Medical Examiner's Office (M.B.), CA; Maryland Office of the Chief Medical Examiner (L.L., D.R.F.), Baltimore; New York City Office of Chief Medical Examiner (J.K.G.), New York; and Division of Neurology, Department of Paediatrics (A.E.K., E.J.D.), the Hospital for Sick Children, Toronto, Canada.

Jaclyn E Yang (JE)

From the Department of Neurology (E.C., O.D., M.W.K., J.E.Y., D.F.), NYU School of Medicine; Department of Epidemiology (D.C.H.), Columbia University Medical Center, New York, NY; San Diego County Medical Examiner's Office (M.B.), CA; Maryland Office of the Chief Medical Examiner (L.L., D.R.F.), Baltimore; New York City Office of Chief Medical Examiner (J.K.G.), New York; and Division of Neurology, Department of Paediatrics (A.E.K., E.J.D.), the Hospital for Sick Children, Toronto, Canada.

Anne E Keller (AE)

From the Department of Neurology (E.C., O.D., M.W.K., J.E.Y., D.F.), NYU School of Medicine; Department of Epidemiology (D.C.H.), Columbia University Medical Center, New York, NY; San Diego County Medical Examiner's Office (M.B.), CA; Maryland Office of the Chief Medical Examiner (L.L., D.R.F.), Baltimore; New York City Office of Chief Medical Examiner (J.K.G.), New York; and Division of Neurology, Department of Paediatrics (A.E.K., E.J.D.), the Hospital for Sick Children, Toronto, Canada.

Elizabeth J Donner (EJ)

From the Department of Neurology (E.C., O.D., M.W.K., J.E.Y., D.F.), NYU School of Medicine; Department of Epidemiology (D.C.H.), Columbia University Medical Center, New York, NY; San Diego County Medical Examiner's Office (M.B.), CA; Maryland Office of the Chief Medical Examiner (L.L., D.R.F.), Baltimore; New York City Office of Chief Medical Examiner (J.K.G.), New York; and Division of Neurology, Department of Paediatrics (A.E.K., E.J.D.), the Hospital for Sick Children, Toronto, Canada.

Daniel Friedman (D)

From the Department of Neurology (E.C., O.D., M.W.K., J.E.Y., D.F.), NYU School of Medicine; Department of Epidemiology (D.C.H.), Columbia University Medical Center, New York, NY; San Diego County Medical Examiner's Office (M.B.), CA; Maryland Office of the Chief Medical Examiner (L.L., D.R.F.), Baltimore; New York City Office of Chief Medical Examiner (J.K.G.), New York; and Division of Neurology, Department of Paediatrics (A.E.K., E.J.D.), the Hospital for Sick Children, Toronto, Canada. Daniel.Friedman@nyulangone.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH